Test Catalog Search Results
AH50 - Overview: Alternative Complement Pathway, Functional, Serum
Investigation of suspected alternative pathway complement deficiency, atypical hemolytic uremic syndrome, C3 glomerulonephritis, and dense-deposit disease
LALBS - Overview: Lysosomal Acid Lipase, Blood Spot
Evaluation of patients with a clinical presentation suggestive of lysosomal acid lipase deficiency using blood spot specimens This test is not useful to determine carrier status for cholesteryl ester storage disease or Wolman disease.
MBLF - Overview: Mannan Binding Lectin Complement Pathway, Functional, Serum
Investigating recurrent meningococcal disease in young children Investigating recurrent or severe infections in adults Investigating glomerular kidney diseases Additionally, deficiencies or dysregulation within the complement system may...
TGQN - Overview: Thyroglobulin, Tumor Marker, Serum
Quantitative thyroglobulin measurement as a part of evaluating suspected interference from heterophile antibodies causing a falsely elevated thyroglobulin result
VITAE - Overview: Vitamin A and Vitamin E, Serum
Diagnosing vitamin A deficiency and toxicity Evaluating persons with intestinal malabsorption of lipids Monitoring of Vitamin E supplementation/treatment
ARSBW - Overview: Arylsulfatase B, Leukocytes
Supporting the biochemical diagnosis of mucopolysaccharidosis type VI (MPS VI, Maroteaux-Lamy syndrome) in whole blood specimens This test is not useful for carrier detection for MPS VI.
MPSBS - Overview: Mucopolysaccharidosis, Blood Spot
Supporting the biochemical diagnosis of mucopolysaccharidoses types I, II, III, IV, or VI Quantification of heparan sulfate, dermatan sulfate, and keratan sulfate in dried blood spot specimens
MPSWB - Overview: Mucopolysaccharidosis, Blood
Supporting the biochemical diagnosis of mucopolysaccharidoses type I, II, III, IV, or VI Quantification of heparan sulfate, dermatan sulfate, and keratan sulfate in whole blood specimens
TGAB - Overview: Thyroglobulin Antibody, Serum
As an adjunct in the diagnosis of autoimmune thyroid diseases: Hashimoto disease, postpartum thyroiditis, neonatal hypothyroidism, and Graves disease
ADMI - Overview: ADAMTS13 Interpretation
Technical interpretation of testing performed to assist in the diagnosis of congenital, immune, or acquired thrombotic thrombocytopenic purpura
CDOMB - Overview: Cadmium for Occupational Monitoring, Blood
Detecting exposure to cadmium, a toxic heavy metal, as a part of occupational monitoring
CDB - Overview: Cadmium, Blood
Detecting exposure to cadmium, a toxic heavy metal
CGAK - Overview: Chromogranin A, Serum
Aiding in monitoring disease progression during the course of disease and treatment in patients with gastroenteropancreatic neuroendocrine tumors (grade 1 and grade 2) when used in conjunction with other clinical methods This test is not...
SER - Overview: Serotonin, Serum
In conjunction with, or as an alternative to, first-order tests in the differential diagnosis of isolated symptoms suggestive of carcinoid syndrome, in particular flushing (5-hydroxyindoleacetic acid or serum chromogranin A measurements are...
TTRX - Overview: Amyloidosis, Transthyretin-Associated Familial, Reflex, Blood
Diagnosis of adult individuals suspected of having transthyretin-associated familial amyloidosis
TGMS - Overview: Thyroglobulin Mass Spectrometry, Serum
Accurate measurement of serum thyroglobulin (Tg) in patients with known or suspected antithyroglobulin autoantibodies (TgAb) or heterophile antibodies (HAb) Reflex testing of samples with previously unknown TgAb status that prove TgAb...
ARSBB - Overview: Arylsulfatase B, Blood Spot
Supporting the biochemical diagnosis of mucopolysaccharidosis type VI (MPS VI, Maroteaux-Lamy syndrome) This test is not useful for carrier detection for MPS VI
AADAM - Overview: ADAMTS13 Profile Interpretation
Technical interpretation of a profile to assist with the diagnosis of congenital, immune, or acquired thrombotic thrombocytopenic purpura including inhibitor studies
GENTA - Overview: Gentamicin, Trough, Serum
Monitoring adequacy of drug clearance during gentamicin therapy
NOTRP - Overview: Nortriptyline, Serum
Monitoring nortriptyline concentration during therapy Evaluating potential nortriptyline toxicity May aid in evaluating patient compliance
Interpretation for CIDP / Chronic Inflammatory Demyelinating Polyradiculoneuropathy/Nodopathy Evaluation, Serum
IFG23 - Overview: Intact Fibroblast Growth Factor 23, Serum
Diagnosing and monitoring tumor induced osteomalacia Diagnosing X-linked hypophosphatemia or autosomal dominant hypophosphatemic rickets Diagnosing familial tumoral calcinosis with hyperphosphatemia
RAVMP - Overview: Ravulizumab Monitoring Panel, Serum
Monitoring of complement blockage by ravulizumab Assessing the response to ravulizumab therapy Assessing the need for dose escalation Evaluating the potential for dose deescalation or discontinuation of therapy in remission...
TAB - Overview: Thyroid Autoantibodies Profile, Serum
As an adjunct in the diagnosis of autoimmune thyroid diseases: Hashimoto disease, postpartum thyroiditis, neonatal hypothyroidism, and Graves disease Differentiating thyroid autoimmune disorders from nonautoimmune goiter or...
Providing a comprehensive genetic evaluation for patients with a personal or family history suggestive of an inborn error of immunity (IEI) associated with immune dysregulation or autoimmunity Establishing a diagnosis of an IEI, allowing...
GAAWR - Overview: Acid Alpha-Glucosidase Reflex, Leukocytes
Diagnosis of Pompe disease as a confirmatory reflex of the 6-enzyme panel
IMIPR - Overview: Imipramine and Desipramine, Serum
Monitoring imipramine and desipramine concentrations during therapy Evaluating potential imipramine and desipramine toxicity May aid in evaluating patient compliance
JAKXR - Overview: JAK2 Exon 12-15 Sequencing, Polycythemia Vera Reflex, Varies
Aiding in the distinction between the myeloproliferative neoplasm polycythemia vera (PV) and other secondary erythrocytosis Evaluating for mutations within exons 12 to 15 of JAK2 in an algorithmic process as part of PVJAK / Polycythemia...
GENRA - Overview: Gentamicin, Random, Serum
Monitoring adequacy of serum concentration during gentamicin therapy in specimens for which no collection timing information is provided
GENPA - Overview: Gentamicin, Peak, Serum
Monitoring adequacy of drug clearance during gentamicin therapy
ECHNG - Overview: Echinococcus Antibody, IgG, Serum
Detection of antibodies to Echinococcus granulosus
MYGLU - Overview: Myoglobin, Random, Urine
Confirming the presence of a myopathy
TLUCR - Overview: Thallium/Creatinine Ratio, Random, Urine
Detecting toxic thallium exposure in random urine specimen
TLU - Overview: Thallium, 24 Hour, Urine
Detecting toxic thallium exposure in 24-hour urine collections
ZNU - Overview: Zinc, 24 Hour, Urine
Identifying the cause of abnormal serum zinc concentrations using 24-hour urine specimens
ZNUCR - Overview: Zinc/Creatinine Ratio, Random, Urine
Identifying the cause of abnormal serum zinc concentrations using a random urine specimen
ZNCU - Overview: Zinc/Creatinine Ratio, Urine
Measurement of zinc concentration as a part of identifying the cause of abnormal serum zinc concentrations using a random urine specimen
TRYPP - Overview: Tryptophan, Plasma
Investigating inadequate tryptophan intake and monitoring dietary treatment
IETG - Overview: Interference Evaluation Heterophile, Thyroglobulin Tumor Marker, Serum
Evaluation of suspected interference from heterophile antibodies causing a falsely elevated thyroglobulin result
Detection of high-risk (HR) genotypes associated with the development of cervical cancer An aid in triaging women with abnormal Pap smear test results Individual genotyping of human papillomavirus (HPV)-16 and/or HPV-18, if present...
SERU - Overview: Serotonin, 24 Hour, Urine
Diagnosis of a small subgroup of carcinoid tumors that produce predominately 5-hydroxytryptophan (5-HTP) but very little serotonin and chromogranin A Follow-up for patients with known or treated carcinoid tumors that produce predominately...
SMN1Z - Overview: SMN1 Gene, Full Gene Analysis, Varies
Confirming a diagnosis of spinal muscular atrophy due to nucleotide variants in SMN1 gene Second-tier carrier screening when there is a family history of spinal muscular atrophy, but an affected individual is not available for testing, or...
MPSER - Overview: Mucopolysaccharides Quantitative, Serum
Quantification of dermatan sulfate, heparan sulfate, and keratan sulfate in serum to support the biochemical diagnosis of mucopolysaccharidoses types I, II, III, IV, VI, or VII
CSFME - Overview: Meningitis/Encephalitis Pathogen Panel, PCR, Spinal Fluid
Rapid detection of meningitis and encephalitis caused by: -Escherichia coli K1 (K1 serotype only) -Haemophilus influenzae -Listeria monocytogenes -Neisseria meningitidis (encapsulated strains only) -Streptococcus agalactiae (Group B...
PLSD - Overview: Lysosomal and Peroxisomal Disorders Screen, Blood Spot
Evaluation of patients with a clinical presentation suggestive of a lysosomal disorder, specifically Gaucher, infantile neurovisceral or chronic visceral acid sphingomyelinase deficiency, Pompe, Krabbe, or Fabry disease, or...
PTHRP - Overview: Parathyroid Hormone-Related Peptide, Plasma
Aiding in the evaluation of individuals with hypercalcemia of unknown origin Aiding in the evaluation of individuals with suspected humoral hypercalcemia of malignancy The test should not be used to exclude cancer or screen individuals...
PNTFT - Overview: Phenytoin, Total and Free, Serum
Monitoring for appropriate therapeutic concentration of both free and total phenytoin: free phenytoin level is the best indicator of adequate therapy in renal failure
MINT - Overview: Molecular Interpretation
Interpretation of the hereditary erythrocytosis profile
SLO - Overview: Smith-Lemli-Opitz Screen, Plasma
Diagnosing Smith-Lemli-Opitz syndrome (7-dehydrocholesterol reductase deficiency)
HEXAZ - Overview: Tay-Sachs Disease, HEXA Gene, Full Gene Analysis, Varies
Second-tier test for confirming a biochemical diagnosis of Tay-Sachs disease (TSD) Carrier testing of individuals with a family history of TSD but an affected individual is not available for testing or disease-causing mutations have not...